Cease and Desist Order issued to Sanofi for advertising its dengue vaccine

A Summons with Cease and Desist Order was issued by the Philippine Food and Drug Administration (FDA) against pharmaceutical giant Sanofi Pasteur Inc. for airing television and radio advertisements of its dengue vaccine, Dengvaxia. The Department of Health (DOH) disclosed that the FDA’s Center for Drug Regulation and Research has monitored the airing of the advertising materials on dengue vaccination, and has also reported the unauthorized promotion of dengue vaccine in the malls.

In the Summons issued by FDA last December 13, 2016, Sanofi was directed to cease and desist from disseminating advertisements for Dengvaxia in any form of mass or social media. To note, the airing of the advertisement is in violation of Administrative Order No. 65 s. 1989 prohibiting advertisement in any form of prescription or ethical drug, it was disclosed. Sanofi was also directed to stop activities promoting and marketing the vaccine. As of December 15, 2016, on the other hand, the company has failed to comply with FDA’s directive to take down the said advertisements. “Since Sanofi has not complied, we have issued summons directing them to cease and desist from airing the advertisements and Show Cause why they should not be penalized for violating the law,” said FDA Director General Nela Charade G. Puno. “The FDA already sent letters to TV and Radio Stations directing them not to air the said unauthorized ads. We are looking forward to their cooperation in our mandate to ensure that the public is provided only with the correct information on the food, drugs, cosmetics, and health devices that they use,” Puno added.
Share on Google Plus
    Blogger Comment
    Facebook Comment


Post a Comment